Pharma Mar SA

PHM
Real-time TRADEGATE AG - 03/26 01:36:31 pm
1.484EUR
+0.20%
Prev.1.4720
Open1.4730
High1.4980
Low1.4400
Volume658 238
Financials
Sales 2019 136 M
EBIT 2019 -12,7 M
R. net 2019 2,50 M
Debt 2019 105 M
Rend. 2019 -
P/E ratio 2019 29,44
P/E ratio 2020
EV / Sales 2019 3,17x
EV / Sales 2020 2,96x
Capitalization 328 M
Company
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and...
Sector :
Biopharmaceuticals
Calendar :
2019-04-22 Earnings Release
Trading Rating : -
Investor Rating :
Latest news
08:45aPHARMA MAR : PharmaMar to attend the China Healthcare Investment Conference (CHIC)
PU
03/25PHARMA MAR : PharmaMar announces positive results in its lurbinectedin monotherapy trial for small cell lung cancer
PU
03/25R&D : new licenses, patents and registered trademarks
PU
03/21PHARMA MAR : Soft Tissue Sarcoma requires a multidisciplinary approach to reduce patient relapses and improve patient survival
PU
01/08PHARMA MAR : Liquidity contracts and specialists
PU
2018PHARMA MAR : Phase II trial of lurbinectedin in progressive mesothelioma finalizes its patient recruitment
PU
2018PHARMA MAR : PharmaMar announces the approval of AplidinŽ in Australia for the treatment of multiple myeloma
PU
2018R&D : new licenses, patents and registered trademarks
PU
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance1,581,581,67
Spread/Res.-5,9%-5,9%-11%
Spread/Supp.15%62%62%
Support1,290,920,92